Patent Grant
6979315
The present invention relates to implantable apparatus for delivering beneficial agents, including drugs to a living body. More particularly, the present invention relates to implantable flow control devices for controlling delivery of beneficial agents to a living body.
It is known to provide implanted drug infusion pumps to deliver a controlled, sustained dosage of beneficial agent or drug to the living human body. Such infusion pumps are generally classified as fixed rate infusion pumps or variable rate infusion pumps. Fixed rate infusion pumps deliver drug-carrying fluid at a preset flow rate, which cannot be changed after manufacture. Variable flow rate implantable pumps permit adjustment of the flow rate, but only prior to implantation. Readjustment of the flow rate of variable rate pumps requires removal of the pump from the patient's body and related surgery. Because of the surgical intrusiveness typically required for flow rate changes for both fixed rate and adjustable rate pumps, there has developed a trend towards selectable-rate pumps, which permit flow adjustment while the pump remains implanted in the living body.
Flow control in selectable rate pumps, however, is complicated by the need to limit or minimize the power consumption. To this end, there have been efforts to provide passive flow control elements on selectable rate pumps for minimizing power consumption while providing flow control.
For example, U.S. Pat. No. 5,820,589, to Torgerson and McMullen, the subject matter of which is incorporated herein, in its entirety, discloses the concept of an implantable pump, which is provided with a passive regulator in the form of a manifold communicating with a restrictor network, with a number (n) of bi-stable valves with two flow states, or a number (n) of multi-stable valves with a number (m) of flow states. With the bi-stable valve configuration, the combination overall allows for 2n flow rate options. With the multi-stable valves, the system has mn flow rate options. Ideally, such bi-stable or multi-stable valves, which can be referred to as passive flow rate control elements, would have no requirement for power except during flow state changes. Power is typically provided via RF signal with suitable electronic implements provided on the pump for providing an induced voltage from the RF signal. While such known passive flow control systems provide variability in flow rates, the number of attainable flow configurations is somewhat limited. It would therefore be desirable to provide an implantable pump with a passive flow control system which provides increased adjustability in flow rates over known systems.
In drug infusion applications, it is frequently desirable to provide for the introduction of a drug bolus to the patient. Bolus dosage may be required, for example, when a patient's activity results in increased pain that is not adequately controlled with normal dosage. Known passive control systems do not provide for the administering of a drug bolus. Thus, there is a need to provide an implantable pump with a passive flow control system which permits the metering and delivery of a bolus of drug.
The present invention solves the aforementioned problems and others by providing an implantable drug infusion pump with a passive flow control device with increased variability in flow settings over heretofore known devices. In a preferred embodiment, the invention provides a bi-stable valve which is duty-cycled by a control module to achieve a desired average flow rate over time. The control module provides appropriate signals at appropriate times to open and close the valve to achieve a desired average flow rate over time. A flow restrictor may be provided downstream of the valve as a safety feature to limit flow or to achieve a desired flow rate range.
The invention also provides a drug infusion pump with a passive flow control device which provides for metering and delivery of a bolus of drug. In a preferred embodiment, a flow conduit communicates with the pressurized reservoir and with a first normally closed, bi-stable valve. The first bi-stable valve is in fluid communication with an accumulator for accumulating a bolus of drug. A second bistable valve isolates the drug supply stored in the accumulator from a drug delivery catheter. To meter a drug bolus into the accumulator, a control module provides an appropriate signal to open and close the first valve and permit ingress of a desired amount of drug to the accumulator. The inlet valve is closed after the bolus has accumulated. When a bolus delivery is desired, the control module delivers appropriate signals to the second valve to release the bolus from the accumulator.
The invention will be described with reference to the drawings, which form a part of this specification. Those of ordinary skill will understand that the invention is not intended to be limited to these exemplary embodiments illustrated in the drawings, of which:
In accordance with the invention, each valve V1–V5 is provided with a respective control signal along a signal path from the control module 50. Consistent with known telemetry techniques, control module 50, in conjunction with radio frequency (RF) receiver 16, provides power, in the form of a voltage signal to the respective valves V1–V5. The voltage signals are preferably in the form of impulses of sufficient duration and magnitude to change the state of the valves V1–V5. Control module 50 thus generates respective signals to each of valves V1–V5, based on signals received from RF receiver 16 corresponding to a particular desired one of the available flow rate settings.
In accordance with the invention, the respective flow rates for restrictors R1–R5 are selected to provide a desired range of flows. Typically, a flow rate range between 10 and 2000 μL/day (microliters per day) are practical for most drug administering applications. Preferably, the flow rates of restrictors R1–R5 are related to provide a uniform interval of flow rate increase or decrease for changed states of valves V1–V5. For example, each restrictor may be adapted to provide twice the flow rate of the adjacent and lower flowing restrictor: restrictor R1 may be adapted to provide a flowrate of 10 μL/day, restrictor R2 a flow rate of 20 uL/day, restrictor R3 a flow rate of 40 μL/day, restrictor R4 a flow rate of 80 μL/day and restrictor R5 a flow rate of 160 μL/day. Thus, to achieve a desired range of 10 to 2000 μL/day, with adjustment intervals of 10 μL/day, eight restrictors and corresponding bi-stable valves would be required.
As will be appreciated by those of ordinary skill, the valves 102 of flow control device 100 may be implemented in micromachinery as detailed, for example, in U.S. Pat. No. 5,839,467 to Saaski et al, the subject matter of which is incorporated herein by reference in its entirety. Similarly, restrictors 104 may be provided as micromachined elements or capillary tubes, for example. Alternatively, valves 102 may be macromachined bi-stable elements, including but not limited to solenoid valves, piezoelectric operated valves, or shape memory alloy actuated valves incorporating NITONOL, for example.
Referring now to
In accordance with the present invention, control module 250 provides signals to periodically change the state of valve 202 to achieve a desired flow rate. Referring to
Those of ordinary skill will recognize that a virtually infinite number of average flow rates may be selected by appropriate selection of the duration of time that the valve 202 remains in each of the two states. It will be appreciated that the duty cycling described with respect to
Referring now to
In operation, upon appropriate telemetry to RF receiver 16 indicating that an operator, or the patient, has requested a bolus of drug, control module 320 provides a first signal to inlet valve 304 to maintain inlet valve 304 in an open state for a predetermined time, corresponding to the amount of drug to be included in the bolus. Under pressure from reservoir 12, drug flows into accumulator. When the predetermined period of time has expired, inlet valve 304 closes. Subsequently, control module 320 initiates a control signal to outlet valve 308 and holds outlet valve 308 in an open state to permit the bolus of drug, which is pressurized within the accumulator, to be delivered to the outlet conduit 310.
Although the preferred embodiment of this invention has been described above in some detail, it should be appreciated that a variety of embodiments will be readily apparent from the foregoing description to persons of ordinary skill. The description is intended to be illustrative of the preferred embodiment of this invention and not intended to be limiting to the scope of protection sought by the applicants, which scope is defined by the appended claims.
This application is a continuation of and claims priority to U.S. application Ser. No. 09/303,004, filed Apr. 30, 1999.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3941126 | Dietrich et al. | Mar 1976 | A |
| 4077405 | Haerten et al. | Mar 1978 | A |
| 4193397 | Tucker et al. | Mar 1980 | A |
| 4258711 | Tucker et al. | Mar 1981 | A |
| 4447224 | DeCant et al. | May 1984 | A |
| 4604089 | Santangelo et al. | Aug 1986 | A |
| 4696671 | Epstein et al. | Sep 1987 | A |
| 4828545 | Epstein et al. | May 1989 | A |
| 4838887 | Idriss | Jun 1989 | A |
| 4865584 | Epstein et al. | Sep 1989 | A |
| 4898583 | Borsanyi et al. | Feb 1990 | A |
| 4898585 | Borsanyi et al. | Feb 1990 | A |
| 5049141 | Olive | Sep 1991 | A |
| 5100380 | Epstein et al. | Mar 1992 | A |
| 5267964 | Karg | Dec 1993 | A |
| 5281210 | Burke et al. | Jan 1994 | A |
| 5304126 | Epstein et al. | Apr 1994 | A |
| 5318515 | Wilk | Jun 1994 | A |
| 5464392 | Epstein et al. | Nov 1995 | A |
| 5820589 | Torgerson et al. | Oct 1998 | A |
| 5839467 | Saaski et al. | Nov 1998 | A |
| Number | Date | Country |
|---|---|---|
| 196 42 234 | Apr 1998 | DE |
| 19642234 | Apr 1998 | DE |
| 0039124 | Nov 1981 | EP |
| 0079405 | May 1983 | EP |
| 0 134 614 | Mar 1985 | EP |
| 0134614 | Mar 1985 | EP |
| 0254031 | Jan 1988 | EP |
| 0342947 | Nov 1989 | EP |
| 0420620 | Apr 1991 | EP |
| 0424494 | Mar 1994 | EP |
| 0860173 | Aug 1998 | EP |
| 1506305 | Apr 1978 | GB |
| WO 8700758 | Feb 1987 | WO |
| WO 9116091 | Oct 1991 | WO |
| WO 9115258 | Oct 1991 | WO |
| WO 9938551 | Aug 1999 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20020087120 A1 | Jul 2002 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 09303004 | Apr 1999 | US |
| Child | 10052077 | US |
